Cargando…

Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis

Coagulation factor XI (FXI) promotes fibrin formation and inhibits fibrinolysis. Elevated plasma FXI levels, limited to a single measurement, are associated with a higher thrombotic risk. Our case–control study aimed to identify the effect of persistently increased plasma FXI levels on the risk of d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spiezia, Luca, Forestan, Chiara, Campello, Elena, Simion, Chiara, Simioni, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420025/ https://www.ncbi.nlm.nih.gov/pubmed/37568292 http://dx.doi.org/10.3390/jcm12154890

Ejemplares similares

Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
por: Poletto, Francesco, et al.
Publicado: (2022)

Clinical Pharmacology of Factor XI Inhibitors: New Therapeutic Approaches for Prevention of Venous and Arterial Thrombotic Disorders
por: Campello, Elena, et al.
Publicado: (2022)

POST-discharge thromboprophylaxis in patients with COVID-19: a single-center experience
por: Simion, Chiara, et al.
Publicado: (2022)

Clinical Values of Coagulation Factors X, XI, and XII in Cerebral Venous Sinus Thrombosis During Perinatal State
por: Li, Ming, et al.
Publicado: (2023)

The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study
por: Tormene, Daniela, et al.
Publicado: (2021)

Coagulation Factor XIII in Cerebral Venous Thrombosis
por: Li, Bojun, et al.
Publicado: (2019)

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
por: Zanetto, Alberto, et al.
Publicado: (2018)

Associations between coagulation factor XII, coagulation factor XI, and stability of venous thromboembolism: A case-control study
por: Meng, Yan, et al.
Publicado: (2022)

Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
por: Campello, Elena, et al.
Publicado: (2020)

Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation
por: Heal, Samantha L., et al.
Publicado: (2022)

Role of factor VIII, IX, and XI in venous thrombosis recurrence risk in adults and children: A systematic review
por: Bosch, Alessandra, et al.
Publicado: (2023)

More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared With Other Pneumonia
por: Spiezia, Luca, et al.
Publicado: (2020)

WITHDRAWN: More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared to Other Oneumonia
por: Spiezia, Luca, et al.
Publicado: (2021)

Procoagulant factor levels and risk of venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2020)

Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19
por: Campello, Elena, et al.
Publicado: (2022)

Regulation of Coagulation Factor XI Expression by MicroRNAs in the Human Liver
por: Salloum-Asfar, Salam, et al.
Publicado: (2014)

Cys482Trp Missense Mutation in the Coagulation Factor XI Gene (F11) in a Korean Patient with Factor XI Deficiency
por: Choi, Seung Jun, et al.
Publicado: (2014)

Influence of Lower Extremity Deep Venous Thrombosis in Cerebral Infarction on Coagulation Index and Thromboelastogram and Its Risk Factors
por: Jin, Tao, et al.
Publicado: (2022)

Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project
por: Bernardi, Enrico, et al.
Publicado: (2022)

Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
por: Campello, Elena, et al.
Publicado: (2021)

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
por: Bortoluzzi, Cristiano, et al.
Publicado: (2022)

Retracted: Influence of Lower Extremity Deep Venous Thrombosis in Cerebral Infarction on Coagulation Index and Thromboelastogram and Its Risk Factors
por: Healthcare Engineering, Journal of
Publicado: (2022)

ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism
por: Porres-Aguilar, Mateo
Publicado: (2023)

COVID‐19 and Venous Thromboembolism in Intensive Care or Medical Ward
por: Avruscio, Giampiero, et al.
Publicado: (2020)

Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation
por: Morla, Shravan, et al.
Publicado: (2022)

Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study
por: Campello, Elena, et al.
Publicado: (2022)

The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events
por: Sharman Moser, Sarah, et al.
Publicado: (2021)

Factor V levels and risk of venous thrombosis: The MEGA case‐control study
por: Rietveld, Inge M., et al.
Publicado: (2018)

Factor XI, a potential target for anticoagulation therapy for venous thromboembolism
por: Li, Tingting, et al.
Publicado: (2022)

How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report
por: Zanon, Ezio, et al.
Publicado: (2020)

Correction to: Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Cerruti, Lorenzo, et al.
Publicado: (2020)

Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Lorenzo, Cerruti, et al.
Publicado: (2020)

Cerebral venous sinus thrombosis after COVID-19 vaccination and congenital deficiency of coagulation factors: Is there a correlation?
por: Mele, Federica, et al.
Publicado: (2022)

Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study
por: Yap, Eng Soo, et al.
Publicado: (2023)

Risk factors of venous thrombosis in knee joint endoprosthesis
por: Vlasov, SV, et al.
Publicado: (2012)

Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019
por: Thondapu, Vikas, et al.
Publicado: (2021)

Low levels of tissue factor pathway inhibitor increase the risk of cerebral venous thrombosis
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2015)

Whole-blood hypocoagulable profile correlates with a greater risk of death within 28 days in patients with severe sepsis
por: Boscolo, Annalisa, et al.
Publicado: (2020)

Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI
por: Puy, Cristina, et al.
Publicado: (2016)

Genetic Variants of Coagulation Factor XI Show Association with Ischemic Stroke Up to 70 Years of Age
por: Hanson, Ellen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cslk84snk6ug4stksvtgcrhfav